Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 8Uterine Cervical Neoplasms 6Carcinoma, Renal Cell 5Rectal Neoplasms 4Pancreatic Neoplasms 4Colonic Neoplasms 4Sarcoma 3Neoplasms 3Lymphoma 3Lung Neoplasms 3Hodgkin Disease 3Breast Neoplasms, Male 3Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Liver Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Adenocarcinoma, Follicular 2von Hippel-Lindau Disease 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Stage III Lung Non-Small Cell Cancer AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 5lenvatinib 3cabozantinib 3Sunitinib 3Iodine-131 3trametinib 2Fluorodeoxyglucose F18 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vandetanib 1tremelimumab 1tanespimycin 1romidepsin 1pembrolizumab 1omipalisib 1durvalumab 1dabrafenib 1cediranib 1aflibercept 1Vorinostat 1Thyrotropin Alfa 1Specimen Handling 1Sorafenib 1Pharmacogenomic Testing 1Nivolumab 1Lenalidomide 1Ipilimumab 1Iodine-124 1Gefitinib 1Decitabine 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma, Follicular × Fluorodeoxyglucose F18 × Clear all
NCT00085293 2018-11-29

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

National Cancer Institute (NCI)

Phase 2 Completed
12 enrolled 4 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00729157 2017-03-15

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

National Cancer Institute (NCI)

Phase 2 Completed
41 enrolled 10 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡